Associate Director, Market Development, Oncology & Emerging Markets

• Identify and validate new market opportunities across oncology, clinical, research, and applied genomics
• Develop market development strategies with clear priorities and measurable commercial outcomes
• Build partnerships with customers, KOLs, academic institutions, clinical organizations, biopharma companies, and professional societies
• Lead evidence-generation initiatives that support adoption and market entry
• Translate scientific and market insights into compelling commercial value propositions
• Support sales teams on strategic accounts, pipeline development, and complex opportunities
• Provide input into product, workflow, and portfolio strategy
• Help shape standards, guidelines, and market-access pathways where appropriate
• Build repeatable frameworks and best practices as the global Market Development function grows
• An advanced degree in genomics, molecular biology, life sciences, medicine, or a related discipline is preferred. A PhD, MD, or MBA is advantageous.
• Significant experience to Next Generation Sequencing or extensive experience in genomics or oncology.
• Demonstrated success in market development, commercialization, strategic partnerships, or market creation
• Strong understanding of clinical, research, and applied genomics markets across the Americas
• Experience working with KOLs, scientific collaborators, professional societies, or policy stakeholders
• Ability to translate complex science into clear commercial and customer value
• Strong cross-functional leadership and influence in a global, matrixed organization
• A hands-on, entrepreneurial approach and comfort working in an evolving environment
• An established network across relevant oncology, genomics, clinical, biopharma, or policy communities
• Willingness to 30% travel across the Americas

Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.

The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis.

The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins.

The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.

With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.